Delivery Order SPE2DB20D1100-SPE2DB24FC4L5

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,372.07 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, on May 1, 2024, with a completion date of May 2, 2024. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,174.05, is for the delivery of TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for...
This federal contract award, valued at $4,240.57, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, and is a firm fixed price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOPAMAX 50 MG TABLET 60S. The contract has a ceiling value of $1,314.55 and is a firm fixed-price delivery order with an ultimate completion date of April 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization registered in the System...
This federal contract award is for the delivery of Topamax 200 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,333.41 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 9, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of TOPAMAX 50 MG TABLET 60S. The contract has a ceiling value of $4,560.69 and is a Firm Fixed Price Delivery Order that runs through February 26, 2024. The contract award is not associated with any set-aside designations, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award is a delivery order worth $1,029 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a medication used to treat various medical conditions. The contract has an ultimate completion date of April 24, 2024 and is a firm fixed-price contract. The award is not associated with a specific set-aside program. AmerisourceBergen, as the prime contractor,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 200 MG TABLET 60S. The $8,026.69 award has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the prime on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,043.72 firm fixed-price delivery order is for the provision of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC4L5
    Delivery Order

This federal contract award is for the supply of TOPAMAX 50 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $2,058.00 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 26, 2024, with a completion date of June 27, 2024. The award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through December 31, 2025, under which the company provides a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. This contract does not have a set-aside designation.

Generated 9/25/24, 9:03 AM